# Enterotoxin-Mediated Development of Staphylococcus aureus Infective Endocarditis

> **NIH NIH R01** · UNIVERSITY OF WISCONSIN-MADISON · 2020 · $595,446

## Abstract

The goal of this proposal is to dissect the underlying mechanism by which enterotoxins cause Staphylococcus
aureus infective endocarditis (IE). S. aureus present a significant clinical and public health problem, causing
some of the most severe hospital- and community-associated illnesses and affecting approximately 500,000
individuals each year in the United States. S. aureus is the leading cause of IE in the developed world,
affecting about 40,000 individuals per year in the U.S. and killing 20-66% of patients. S. aureus IE is also the
most aggressive, tissue destructive, and lethal form of IE. Treatment of S. aureus IE is challenging, requiring
prolonged antibiotic therapy or surgery to remove infected valves. Infections with methicillin-resistant S. aureus
are frequent, complicate treatment, and increase mortality. Little is known about the S. aureus virulence factors
critical for IE development and the mechanisms that lead to such an aggressive form of disease. The
mechanistic understanding of IE is of utmost importance, given that its incidence, severity, and lethality have
not been reduced in the last 50 years. Current evidence suggests that staphylococcal enterotoxin C (SEC),
toxic shock syndrome toxin (TSST1), and the enterotoxin gene cluster (egc) play a novel and essential role in
the etiology of IE caused by S. aureus. Enterotoxin deletion/complementation studies demonstrated the
requirement of SEC, TSST1, and select egc toxins in development of S. aureus IE in a rabbit model of native
valve IE. Staphylococcal enterotoxins are known for their potent superantigenic properties resulting in a CD4+
T cell dependent cytokine storm leading to inflammatory syndromes, toxic shock syndrome, or septic shock.
While adaptive immune system activation is characteristic of staphylococcal enterotoxins, this is not their only
biological function. Enterotoxins also directly interact with endothelial cells, epithelial cells, and adipocytes by a
mechanism independent of superantigenic activity. In epithelial cells, activation is dependent on a
dodecapeptide located at the base of the central a-helix of the molecule. In Aim 1, we will use strains
expressing enterotoxins inactivated in ability to interact with the T cell receptor, MHC-II receptor, or endothelial
cells and the rabbit model of IE to determine whether IE is due to superantigenic activity or dodecapeptide-
mediated effects, or both. IE is an infection of the aortic endothelium. Infection and inflammation of the
vascular endothelium are well-recognized mediators of vascular pathologies, such as atherosclerosis. Hence,
Aim 2 will determine the mechanisms by which enterotoxins affect the endothelium to promote IE development.
For this, we will use the rabbit model of IE, the rabbit aortic explant culture model, and the newly developed
human aortic endothelial cell line to elucidate mechanisms in vivo, ex vivo, and in vitro. We expect our
proposed studies to generate data that will significantly ad...

## Key facts

- **NIH application ID:** 9906166
- **Project number:** 5R01AI134692-04
- **Recipient organization:** UNIVERSITY OF WISCONSIN-MADISON
- **Principal Investigator:** Wilmara Salgado Pabon
- **Activity code:** R01 (R01, R21, SBIR, etc.)
- **Funding institute:** NIH
- **Fiscal year:** 2020
- **Award amount:** $595,446
- **Award type:** 5
- **Project period:** 2018-06-08 → 2023-05-31

## Primary source

NIH RePORTER: https://reporter.nih.gov/project-details/9906166

## Citation

> US National Institutes of Health, RePORTER application 9906166, Enterotoxin-Mediated Development of Staphylococcus aureus Infective Endocarditis (5R01AI134692-04). Retrieved via AI Analytics 2026-05-22 from https://api.ai-analytics.org/grant/nih/9906166. Licensed CC0.

---

*[NIH grants dataset](/datasets/nih-grants) · CC0 1.0*